Status:
COMPLETED
A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder Osteoarthritis
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Osteoarthritis
Musculoskeletal Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This clinical study is to evaluate the safety and efficacy of Synvisc in patients with symptomatic shoulder osteoarthritis (OA). Patients will be given Synvisc, with the possible administration of a s...
Eligibility Criteria
Inclusion
- Patients with symptomatic OA pain of shoulder (gleno-humeral)
Exclusion
- Patients with current or prior conditions or treatment that would impede measurement of efficacy or safety
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00131300
Start Date
April 1 2004
End Date
February 1 2006
Last Update
March 18 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Ambroise Pare
Boulogne-Billancourt, France, 92100
2
Clinique Saint Anne Lumiere
Lyon, France, 69003
3
Centre de Medecine et Traumatologie du Sport Clinique du Sport
Mérignac, France, 33700
4
CHRU Hopital Trousseau
Tours, France, 37044